Clinical achievements, obstacles, falsehoods, and future directions of cell-based neurorestoratology

Cell Transplantation

Volumn 21, Issue SUPPL. 1, 2012, Pages

  Huang, Hongyun ^a,b   Chen, Lin ^a,b   Sanberg, Paul R ^c  

^a Beijing Rehabilitation Center   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell based neurorestoratology; Clinical achievements; Future directions; Obstacles

Indexed keywords

NEUROTROPHIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; ARTICLE; ATAXIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BIOETHICS; BRAIN FUNCTION; CELL BASED NEURORESTORATOLOGY; CELL THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL PALSY; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; DEGENERATIVE DISEASE; DEMENTIA; ECONOMIC ASPECT; GOLD STANDARD; GOVERNMENT REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEDICAL ETHICS; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVE STIMULATION; NEURAL STEM CELL TRANSPLANTATION; NEUROMODULATION; NEUROPROTECTION; NEUROSCIENCE; NEUROSURGERY; OLFACTORY ENSHEATHING CELL; OLFACTORY EPITHELIUM; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); POLITICAL SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIGION; REMYELINIZATION; SCIENTIFIC LITERATURE; SHY DRAGER SYNDROME; SPINAL CORD INJURY; STROKE; TISSUE ENGINEERING; TRAUMATIC BRAIN INJURY;

CENTRAL NERVOUS SYSTEM; HUMANS; NERVE REGENERATION; NERVOUS SYSTEM PHYSIOLOGICAL PROCESSES; NEURODEGENERATIVE DISEASES; NEUROPHYSIOLOGY;

EID: 84930485145     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X633725     Document Type: Article

References (45)

1. Anderberg, L.; Aldskogius, H.; Holtz, A. Spinal cord injury-scientific challenges for the unknown future. Ups. J. Med. Sci. 112(3):259-288; 2007.
2. Battistella, V.; de Freitas, G. R.; da Fonseca, L. M.; Mercante, D.; Gutfilen, B.; Goldenberg, R. C.; Dias, J. V.; Kasai-Brunswick, T. H.; Wajnberg, E.; Rosado-de-Castro, P. H.; Alves-Leon, S. V.; Mendez-Otero, R.; Andre, C. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 6(1):45-52; 2011.
3. Bohbot, A. Olfactory ensheathing glia transplantation combined with LASERPONCTURE in human spinal cord injury: Results measured by electromyography monitoring. Cell Transplant. 19(2):179-184; 2010.
4. Burt, R. K.; Loh, Y.; Cohen, B.; Stefoski, D.; Balabanov, R.; Katsamakis, G.; Oyama, Y.; Russell, E. J.; Stern, J.; Muraro, P.; Rose, J.; Testori, A.; Bucha, J.; Jovanovic, B.; Milanetti, F.; Storek, J.; Voltarelli, J. C.; Burns, W. H. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: A phase I/II study. Lancet Neurol. 8(3):244-253; 2009.
5. Chen, L.; Huang, H. Neurorestoratology: New concept and bridge from bench to bedside. Chin. J. Repar. Reconstr. Surg. 23(3):366-370; 2009.
6. Chen, L.; Huang, H.; Xi, H.; Xie, Z.; Liu, R.; Jiang, Z.; Zhang, F.; Liu, Y.; Chen, D.; Wang, Q.; Wang, H.; Ren, Y.; Zhou, C. Intracranial transplant of olfactory ensheath-ing cells in children and adolescents with cerebral palsy: A randomized controlled clinical trial. Cell Transplant. 19(2):185-191; 2010.
7. Cristante, A. F.; Barros-Filho, T. E.; Tatsui, N.; Mendrone, A.; Caldas, J. G.; Camargo, A.; Alexandre, A.; Teixeira, W. G.; Oliveira, R. P.; Marcon, R. M. Stem cells in the treatment of chronic spinal cord injury: Evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord 47(10):733-738; 2009.
8. Deda, H.; Inci, M. C.; Kürekci, A. E.; Kayihan, K.; Ozgíin, E.; Ustíinsoy, G. E.; Kocabay, S. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 10(6):565-574; 2008.
9. Deda, H.; Inci, M. C.; Kurekci, A. E.; Sav, A.; Kayihan, K.; Ozgíin, E.; Ustíinsoy, G. E.; Kocabay, S. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 11(1):18-25; 2009.
10. Farge, D.; Labopin, M.; Tyndall, A.; Fassas, A.; Mancardi, G. L.; Van Laar, J.; Ouyang, J.; Kozak, T.; Moore, J.; Kotter, I.; Chesnel, V.; Marmont, A.; Gratwohl, A.; Saccardi, R. Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95(2):284-292; 2010.
11. Fassas, A.; Passweg, J. R.; Anagnostopoulos, A.; Kazis, A.; Kozak, T.; Havrdova, E.; Carreras, E.; Graus, F.; Kashyap, A.; Openshaw, H.; Schipperus, M.; Deconinck, E.; Mancardi, G.; Marmont, A.; Hansz, J.; Rabusin, M.; Zuazu Nagore, F. J.; Besalduch, J.; Dentamaro, T.; Fouillard, L.; Hertenstein, B.; La Nasa, G.; Musso, M.; Papineschi, F.; Rowe, J. M.; Saccardi, R.; Steck, A.; Kappos, L.; Gratwohl, A.; Tyndall, A.; Samijn, J.; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 249(8):1088-1097; 2002.
12. Feron, F.; Perry, C.; Cochrane, J.; Licina, P.; Nowitzke, A.; Urquhart, S.; Geraghty, T.; Mackay-Sim, A. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128(Pt. 12):2951-2960; 2005.
13. Geffner, L. F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A. H.; Montenegro, X.; Gonzalez, R.; Silva, F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies. Cell Transplant. 17(12):1277-1293; 2008.
14. Huang, H. Neurorestoratology, a distinct discipline and a new era: A brief introduction to the first IANR section. Cell Transplant. 19:129-131; 2010.
15. Huang, H.; Chen, L.; Sanberg, P. Cell therapy from bench to bedside translation in CNS Neurorestoratology era. Cell Med. 1:15-46; 2010.
16. Huang, H.; Chen, L.; Wang, H.; Xiu, B.; Li, B.; Wang, R.; Zhang, J.; Zhang, F.; Gu, Z.; Li, Y.; Song, Y.; Hao, W.; Pang, S.; Sun, J. Influence of patients' age on functional recovery after transplantation of olfactory ensheath-ing cells into injured spinal cord injury. Chin. Med. J. 116(10):1488-1491; 2003.
17. Huang, H.; Chen, L.; Xi, H.; Wang, H.; Zhang, J.; Zhang, F.; Liu, Y. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: A controlled pilot study. Clin. Transplant. 22(6):710-718; 2008.
18. Huang, H.; Chen, L.; Xi, H.; Wang, Q.; Zhang, J.; Liu, Y.; Zhang, F. Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients. Chin. J. Repar. Reconstr. Surg. 23(1):14-20; 2009.
19. Huang, H. Y.; Wang, H. M.; Xiu, B.; Wang, R.; Lu, M.; Chen, L.; Qi, S. B. Preliminary report of clinical trial for olfactory ensheathing cell transplantation treating the spi-nal cord injury. J. Naval General Hospital PLA 15(1):18-21; 2002.
20. International Association of Neurorestoratology. Beijing declaration of International Association of Neurorestora-tology (IANR). Cell Transplant. 18:487; 2009.
21. Jozwiak, S.; Habich, A.; Kotulska, K.; Sarnowska, A.; Kropiwnicki, T.; Janowski, M.; Jurkiewicz, E.; Lukomska, B.; Kmiec, T.; Walecki, J.; Roszkowski, M.; Litwin, M.; Oldak, T.; Boruczkowski, D.; Domanska-Janik, K. Intra-cerebroventricular transplantation of cord blood-derived neural progenitors in a child with severe global brain ischemic injury. Cell Med. 1(2):71-80; 2010.
22. Karussis, D.; Karageorgiou, C.; Vaknin-Dembinsky, A.; Gowda-Kurkalli, B.; Gomori, J. M.; Kassis, I.; Bulte, J. W.; Petrou, P.; Ben-Hur, T.; Abramsky, O.; Slavin, S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67(10):1187-1194; 2010.
23. Kondziolka, D.; Steinberg, G. K.; Wechsler, L.; Meltzer, C.C.; Elder, E.; Gebel, J.; Decesare, S.; Jovin, T.; Zafonte, R.; Lebowitz, J.; Flickinger, J. C.; Tong, D.; Marks, M. P.; Jamieson, C.; Luu, D.; Bell-Stephens, T.; Teraoka, J. Neurotransplantation for patients with sub-cortical motor stroke: A phase 2 randomized trial. J. Neurosurg. 103(1):38-45; 2005.
24. Kumar, A. A.; Kumar, S. R.; Narayanan, R.; Arul, K.; Baskaran, M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp. Clin. Transplant. 7(4):241-248; 2009.
25. Lee, J. S.; Hong, J. M.; Moon, G. J.; Lee, P. H.; Ahn, Y. H.; Bang, O. Y.; STARTING collaborators. A longterm follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6):1099-1106; 2010.
26. Li, Y.; Bao, J.; Khatibi, N. H.; Chen, L.; Wang, H.; Duan, Y.; Huang, H.; Zhou, C. Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1(G93A) ALS rats through neuroprotection and remyelination. Anat. Rec. 294:847-857; 2011.
27. Lima, C.; Pratas-Vital, J.; Escada, P.; Hasse-Ferreira, A.; Capucho, C.; Peduzzi, J. D. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J. Spinal Cord Med. 29(3):191-206; 2006.
28. Ma, Y.; Tang, C.; Chaly, T.; Greene, P.; Breeze, R.; Fahn, S.; Freed, C.; Dhawan, V.; Eidelberg, D. Dopamine cell implantation in Parkinson's disease: Long-term clinical and (18)F-FDOPA PET outcomes. J. Nucl. Med. 51(1): 7-15; 2010.
29. Mack, G. S. ReNeuron and StemCells get green light for neural stem cell trials. Nat. Biotechnol. 29(2):95-97; 2011.
30. Mackay-Sim, A.; Feron, F.; Cochrane, J.; Bassingth-waighte, L.; Bayliss, C.; Davies, W.; Fronek, P.; Gray, C.; Kerr, G.; Licina, P.; Nowitzke, A.; Perry, C.; Silburn, P. A.; Urquhart, S.; Geraghty, T. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 131(Pt. 9):2376-2386; 2010.
31. Martinez, H. R.; Gonzalez-Garza, M. T.; Moreno-Cuevas, J. E.; Caro, E.; Gutierrez-Jimenez, E.; Segura, J. J. Stemcell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 11(1): 26-34; 2009.
32. Mazzini, L.; Ferrero, I.; Luparello, V.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Stecco, A.; Tarletti, R.; Miglioretti, M.; Fava, E.; Nasuelli, N.; Cisari, C.; Massara, M.; Vercelli, R.; Oggioni, G. D.; Carriero, A.; Cantello, R.; Monaco, F.; Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 223(1):229-237; 2010.
33. Mehta, T.; Feroz, A.; Thakkar, U.; Vanikar, A.; Shah, V.; Trivedi, H. Subarachnoid placement of stem cells in neu-rological disorders. Transplant. Proc. 40(4):1145-1147; 2008.
34. Moviglia, G. A.; Varela, G.; Brizuela, J. A.; Moviglia Brandolino, M. T.; Farina, P.; Etchegaray, G.; Piccone, S.; Hirsch, J.; Martinez, G.; Marino, S.; Deffain, S.; Coria, N.; Gonzáles, A.; Sztanko, M.; Salas-Zamora, P.; Previgliano, I.; Aingel, V.; Farias, J.; Gaeta, C. A.; Saslavsky, J.; Blasseti, N. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord 47(6):499-503; 2009.
35. Park, H. C.; Shim, Y. S.; Ha, Y.; Yoon, S. H.; Park, S. R.; Choi, B. H.; Park, H. S. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 11(5-6):913-922; 2005.
36. Rabinovich, S. S.; Seledtsov, V. I.; Banul, N. V.; Poveshchenko, O. V.; Senyukov, V. V.; Astrakov, S. V.; Samarin, D. M.; Taraban, V. Y. Cell therapy of brain stroke. Bull. Exp. Biol. Med. 139(1):126-128; 2005.
37. Rabinovich, S. S.; Seledtsov, V. I.; Poveschenko, O. V.; Senuykov, V. V.; Taraban, V. Y.; Yarochno, V. I.; Kolosov, N. G.; Savchenko, S. A.; Kozlov, V. A. Transplantation treatment of spinal cord injury patients. Biomed. Pharmacother. 57(9):428-433; 2003.
38. Rama, P.; Matuska, S.; Paganoni, G.; Spinelli, A.; De Luca, M.; Pellegrini, G. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363:4755; 2010.
39. Saiz, A.; Blanco, Y.; Berenguer, J.; Gomez-Choco, M.; Carreras, E.; Arbizu, T.; Graus, F. Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis. Neurologia 23(7):405-407; 2008.
40. Suarez-Monteagudo, C.; Hernandez-Ramirez, P.; Alvarez-Gonzalez, L.; Garcia-Maeso, I.; de la Cuetara-Bernal, K.; Castillo-Dlaz, L.; Bringas-Vega, M. L.; Martinez-Aching, G.; Morales-Chacon, L. M.; Baez-Martin, M. M.; Sanchez-Catasiís, C.; Carballo-Barreda, M.; Rodriguez-Rojas, R.; Gomez-Fernandez, L.; Alberti-Amador, E.; Macias-Abraham, C.; Balea, E. D.; Rosales, L. C.; Del Valle Perez, L.; Ferrer, B. B.; Gonzalez, R. M.; Bergado, J. A. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor. Neurol. Neurosci. 27(3):151-161; 2009.
41. Sykova, E.; Homola, A.; Mazanec, R.; Lachmann, H.; Konradova, S. L.; Kobylka, P.; Padr, R.; Neuwirth, J.; Komrska, V.; Vavra, V.; Stulik, J.; Bojar, M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 15(8-9):675-687; 2006.
42. Xu, J.; Ji, B. X.; Su, L.; Dong, H. Q.; Sun, W. L.; Wan, S.G.; Liu, Y. O.; Zhang, P.; Liu, C. Y. Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Ann. Hematol. 90(3):343-348; 2011.
43. Yamout, B.; Hourani, R.; Salti, H.; Barada, W.; El-Hajj, T.; Al-Kutoubi, A.; Herlopian, A.; Baz, E. K.; Mahfouz, R.; Khalil-Hamdan, R.; Kreidieh, N. M.; El-Sabban, M.; Bazarbachi, A. J. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study. Neuroimmunology 227(1-2):185-189; 2010.
44. Yang, W. Z.; Zhang, Y.; Wu, F.; Min, W. P.; Minev, B.; Zhang, M.; Luo, X. L.; Ramos, F.; Ichimm, T. E.; Riordan, N. H.; Hu, X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J. Transl. Med. 8:75; 2010.
45. Yoon, S. H.; Shim, Y. S.; Park, Y. H.; Chung, J. K.; Nam, J. H.; Kim, M. O.; Park, H. C.; Park, S. R.; Min, B. H.; Kim, E. Y.; Choi, B. H.; Park, H.; Ha, Y. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25(8):2066-2073; 2007.